Strategies for Treatment of Thyroid Cancer

Author:

Yadav Deepika1,Mishra Prem Shankar1,Sharma Pramod Kumar1,Malviya Rishabha1ORCID

Affiliation:

1. Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India

Abstract

Abstract: More people are diagnosed with thyroid cancer than any other endocrine tumor. Differentiated thyroid cancer is often treated by removing the thyroid gland (thyroidectomy), iodizing radiation, or inhibiting thyroid stimulating hormone (TSH). Advanced thyroid carcinomas are notoriously resistant to chemotherapy, thus the pursuit of alternative treatments is vital. The best methods for treating individuals with advanced nonmedullary and medullary thyroid carcinomas are discussed in this post. Numerous tyrosine kinase inhibitors and antiangiogenic inhibitors, two types of novel target therapy, have shown promise in studies for individuals with thyroid cancer. Both the positive and unfavourable outcomes of clinical studies of these drugs were addressed. The findings presented here are encouraging, but more study is required to establish whether or not this method is effective in the treatment of thyroid cancer.

Publisher

Bentham Science Publishers Ltd.

Subject

Clinical Biochemistry,Drug Discovery,Pharmacology,Molecular Medicine

Reference72 articles.

1. Ferlay J.; Bray F.; Pisani P.; Parkin D.M.; Cancer incidence, mortality and prevalence worldwide.GLOBOCAN 2002 IARC Cancer- Base No5, version 20 2004

2. Curado M.P.; Edwards B.; Shin H.R.; Cancer Incidence in Five Continents, vol IX. IARC Press, International Agency for Research on Cancer; 2007

3. Dal Maso L.; Bosetti C.; La Vecchia C.; Franceschi S.; Risk factors for thyroid cancer: an epidemiological review focused on nutritional factors. Cancer Causes Control 2009,20(1),75-86

4. Ozgun A.; Tuncel T.; Emirzeoglu L.; Celik S.; Bilgi O.; Haholu A.; Urhan M.; Karagoz B.; Malignant melanoma and papillary thyroid carcinoma that were diagnosed concurrently and treated simultaneously: A case report. Oncol Lett 2015,9(1),468-470

5. Liska J.; Altanerova V.; Galbavy S.; Stvrtina S.; Brtko J.; Thyroid tumors: histological classification and genetic factors involved in the development of thyroid cancer. Endocr Regul 2005,39(3),73-83

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3